143 related articles for article (PubMed ID: 32016480)
1. Anti‑metastatic effects of arctigenin are regulated by MAPK/AP‑1 signaling in 4T‑1 mouse breast cancer cells.
Lee MG; Lee KS; Nam KS
Mol Med Rep; 2020 Mar; 21(3):1374-1382. PubMed ID: 32016480
[TBL] [Abstract][Full Text] [Related]
2. The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
Maxwell T; Chun SY; Lee KS; Kim S; Nam KS
Int J Oncol; 2017 Feb; 50(2):727-735. PubMed ID: 28035371
[TBL] [Abstract][Full Text] [Related]
3. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells.
Lou C; Zhu Z; Zhao Y; Zhu R; Zhao H
Oncol Rep; 2017 Jan; 37(1):179-184. PubMed ID: 27878294
[TBL] [Abstract][Full Text] [Related]
4. Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy.
Feng T; Cao W; Shen W; Zhang L; Gu X; Guo Y; Tsai HI; Liu X; Li J; Zhang J; Li S; Wu F; Liu Y
Oncotarget; 2017 Jan; 8(1):329-344. PubMed ID: 27861147
[TBL] [Abstract][Full Text] [Related]
5. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition.
Cho MK; Jang YP; Kim YC; Kim SG
Int Immunopharmacol; 2004 Oct; 4(10-11):1419-29. PubMed ID: 15313439
[TBL] [Abstract][Full Text] [Related]
6. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
7. Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes formation.
Jie Z; Xie Z; Zhao X; Sun X; Yu H; Pan X; Shen S; Qin A; Fang X; Fan S
J Cell Physiol; 2019 Apr; 234(4):4167-4178. PubMed ID: 30146723
[TBL] [Abstract][Full Text] [Related]
8. Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA‑induced breast cancer cell invasion via PLCγ2/PKCβ/NF‑κB/AP‑1‑dependent matrix metalloproteinase‑9 activation.
Kim JM; Park J; Noh EM; Song HK; Kang SY; Jung SH; Kim JS; Park BH; Lee YR; Youn HJ
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760219
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines.
Susanti S; Iwasaki H; Inafuku M; Taira N; Oku H
Phytomedicine; 2013 Dec; 21(1):39-46. PubMed ID: 24021157
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.
Huang K; Li LA; Meng YG; You YQ; Fu XY; Song L
Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):507-11. PubMed ID: 24842412
[TBL] [Abstract][Full Text] [Related]
12. The antitumor function of arctigenin in human retinoblastoma cells is mediated by jagged‑1.
Ke N; Liu Q; Pi L; Fang J; Chen L; Chen X
Mol Med Rep; 2019 May; 19(5):3642-3648. PubMed ID: 30896794
[TBL] [Abstract][Full Text] [Related]
13. Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.
Cheng G; Gao F; Sun X; Bi H; Zhu Y
Mol Med Rep; 2016 Oct; 14(4):3199-205. PubMed ID: 27572907
[TBL] [Abstract][Full Text] [Related]
14. Arctigenin but not arctiin acts as the major effective constituent of Arctium lappa L. fruit for attenuating colonic inflammatory response induced by dextran sulfate sodium in mice.
Wu X; Yang Y; Dou Y; Ye J; Bian D; Wei Z; Tong B; Kong L; Xia Y; Dai Y
Int Immunopharmacol; 2014 Dec; 23(2):505-15. PubMed ID: 25284342
[TBL] [Abstract][Full Text] [Related]
15. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.
Janthamala S; Jusakul A; Kongpetch S; Kimawaha P; Klanrit P; Loilome W; Namwat N; Techasen A
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2049-2059. PubMed ID: 34283274
[TBL] [Abstract][Full Text] [Related]
16. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation.
Awale S; Lu J; Kalauni SK; Kurashima Y; Tezuka Y; Kadota S; Esumi H
Cancer Res; 2006 Feb; 66(3):1751-7. PubMed ID: 16452235
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells.
Wang KL; Hsia SM; Chan CJ; Chang FY; Huang CY; Bau DT; Wang PS
Expert Opin Ther Targets; 2013 Apr; 17(4):337-49. PubMed ID: 23327692
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment.
Shabgah AG; Suksatan W; Achmad MH; Bokov DO; Abdelbasset WK; Ezzatifar F; Hemmati S; Mohammadi H; Soleimani D; Jadidi-Niaragh F; Ahmadi M; Navashenaq JG
Eur J Pharmacol; 2021 Oct; 909():174419. PubMed ID: 34391770
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
20. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling.
Shi H; Zhao L; Guo X; Fang R; Zhang H; Dong G; Fu J; Yan F; Zhang J; Ning Z; Ma Q; Li Z; Li C; Dai J; Si C; Xiong H
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
